Fluvoxamine Treatment and D2 Receptors: a Pet Study on OCD Drug-Naïve Patients
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Changes in D(2) receptors during antidepressant therapy have been reported in patients with major depressive disorder using PET/SPET. The aim of this study was to evaluate modifications in D(2) receptors that might occur in patients affected by obsessive-compulsive disorder (OCD) during serotonin reuptake sites inhibitors (SSRIs). To this purpose, we measured the in vivo binding of [(11)C]raclopride ([(11)C]Rac)in the brain of a group of OCD naïve patients before and after the repeated administration of the inhibitor SSRI fluvoxamine. Eight patients with a Diagnostic and Statistical Manual of Mental Disorders IVth edition diagnosis of OCD completed the study undergoing a PET scan and a complete clinical evaluation before and during treatment with fluvoxamine. Patients have been compared also with a group of nine age-matched normal volunteers. Fluvoxamine treatment significantly improved clinical symptoms and increased [(11)C]Rac binding potential (BP) in the basal ganglia of OCD patients (7.5+/-5.2, 6.9+/-6.9, and 9.9+/-9.3% in dorsal caudate, dorsal putamen, and ventral basal ganglia, respectively; p<0.01) to values closer to those observed in the group of normal subjects. Chronic treatment with fluvoxamine induces a slight but significant increase in striatal [(11)C]Rac BP of previously drug-naïve OCD patients. The modifications in D(2) receptor availability might be secondary to fluvoxamine effects on serotoninergic activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a system apparently impaired in OCD (Denys et al. 2004; Hesse et al. 2005; Moresco et al. 2007; Olver et al. 2009, 2010; Perani et al. 2008; Sesia et al. 2013; Van Der Wee et al. 2004)”
From Dopaminergic drug treatment remediates exaggerated cingulate prediction error responses in obsessive-compulsive disorder (2019) · cites this paper as Moresco et al. 2007
In the citing paper
“Evidence from human molecular imaging studies of patients with OCD suggests a possible role for dopaminergic pathology in OCD (Denys et al. 2004; Hesse et al. 2005; Moresco et al. 2007; Olver et al. 2009, 2010; Perani et al. 2008; Sesia et al. 2013; Van Der Wee et al. 2004).”
From Dopaminergic drug treatment remediates exaggerated cingulate prediction error responses in obsessive-compulsive disorder (2019) · cites this paper as Moresco et al. 2007
Citations
Cites
Functional architecture of basal ganglia circuits: neural substrates of parallel processing
Alexander, G. E., & Crutcher, M. D. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90107-l · Cited by 4,131 · cited 2×
“In particular, (a) dopamine regulates cortico-striatal-thalamo-cortical circuits through its activity on indirect and direct pathway (Alexander and Crutcher, 1990); (b) structural damages to the basal ganglia, a region particularly rich in dopamine receptors, promote OCD symptoms (Carmin et al, 2002); (c) a supersensi…”
Background3D statistical neuroanatomical models from 305 MRI volumes
Evans, A. C., Collins, D. L., Mills, S. R., Brown, E. D., Kelly, R. L., & Peters, T. M. (2005) · 1993 IEEE Conference Record Nuclear Science Symposium and Medical Imaging Conference · doi:10.1109/nssmic.1993.373602 · Cited by 1,487 · cited 1×
“Parametric images were then normalized to the Montreal Neurological Institute (MNI) stereotactic space (Evans et al, 1993) using SPM99 software (Wellcome Department of Imaging Neuroscience).”
MethodBaxter, L. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820090009002 · Cited by 1,293 · cited 1×
“This hypothesis is supported by neurological (Laplane et al, 1989), neurosurgical (Mindus et al, 1994; Oliver et al, 2003; Rauch, 2003), and imaging findings (Baxter et al, 1992; Breiter et al, 1996; Saxena et al, 1998; Trivedi, 1996).”
MethodEvidence for striatal dopamine release during a video game
Koepp, M. J., Gunn, R. N., Lawrence, A. D., Cunningham, V. J., Dagher, A., Jones, T., Brooks, D. J., Bench, C. J., & Grasby, P. M. (1998) · Nature · doi:10.1038/30498 · Cited by 1,279 · cited 1×
“This property of [11C]Rac binding, has been used, as an innovative strategy, to measure in living human subjects the modification in extracellular/synaptic dopamine concentration induced by pharmacological or behavioral stimulations (Laruelle, 2000b; Koepp et al, 1998).”
MethodParametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model
Gunn, R. N., Lammertsma, A. A., Hume, S. P., & Cunningham, V. J. (1997) · NeuroImage · doi:10.1006/nimg.1997.0303 · Cited by 1,084 · cited 1×
“Radioactivity distribution images were transformed pixel by pixel into BP images and relative influx images (RI) using the RPM (reversible reference tissue model) software developed by R Gunn et al (Gunn et al, 1997).”
MethodImaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review
Laruelle, M. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200003000-00001 · Cited by 944 · cited 2×
“This property of [11C]Rac binding, has been used, as an innovative strategy, to measure in living human subjects the modification in extracellular/synaptic dopamine concentration induced by pharmacological or behavioral stimulations (Laruelle, 2000b; Koepp et al, 1998).”
BackgroundMethodMultimodal Image Coregistration and Partitioning—A Unified Framework
Ashburner, J., & Friston, K. (1997) · NeuroImage · doi:10.1006/nimg.1997.0290 · Cited by 927 · cited 1×
“5 (Ashburner and Friston, 1997).”
Neuroimaging and frontal–subcortical circuitry in obsessive–compulsive disorder
Saxena, S., Brody, A. L., Schwartz, J. M., & Baxter, L. R. (1998) · British Journal of Psychiatry · doi:10.1192/s0007125000297870 · Cited by 831 · cited 1×
“[11C]Rac binding has been proven to be sensitive to modification in extracellular concentration of exogenous or endogenous dopamine (Seeman et al, 1989; Laruelle, 2000a).”
BackgroundFunctional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder
Breiter, H. C. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830070041008 · Cited by 626 · cited 1×
“This hypothesis is supported by neurological (Laplane et al, 1989), neurosurgical (Mindus et al, 1994; Oliver et al, 2003; Rauch, 2003), and imaging findings (Baxter et al, 1992; Breiter et al, 1996; Saxena et al, 1998; Trivedi, 1996).”
MethodMawlawi, O., Martinez, D., Slifstein, M., Broft, A., Chatterjee, R., Hwang, D.-R., Huang, Y., Simpson, N., Ngo, K., Van Heertum, R., et al. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200109000-00002 · Cited by 525
Cited by
Obsessive-compulsive disorder: An integrative genetic and neurobiological perspective
Pauls, D. L., Abramovitch, A., Rauch, S. L., & Geller, D. A. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3746 · Cited by 793
Obsessive-compulsive disorder: Puzzles and prospects
Robbins, T. W., Vaghi, M. M., & Banca, P. (2019) · Neuron · doi:10.1016/j.neuron.2019.01.046 · Cited by 510
Nikolaus, S., Antke, C., Beu, M., & Müller, H.-W. (2010) · Reviews in the Neurosciences · doi:10.1515/revneuro.2010.21.2.119 · Cited by 243
Nakao, T., Okada, K., & Kanba, S. (2014) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12195 · Cited by 231
“[72] reported that [ 11 C]-Raclopride, which is a selective D2 receptor antagonist, increased the D2 binding potential significantly in the basal ganglia of OCD patients,”
Mosconi, M. W., Kay, M., D'Cruz, A.-M., Seidenfeld, A., Guter, S., Stanford, L. D., & Sweeney, J. A. (2009) · Psychological Medicine · doi:10.1017/s0033291708004984 · Cited by 222
“…be established, but observations that inhibitory control deficits are evident in both groups and are reduced by serotonergic drugs in neuropsychiatric disorders (Rosenberg et al. 2000 ; Moresco et al. 2007) suggest that frontostriatal disruption is one commonality in these behavioral disturbances.”
BackgroundPerani, D., Garibotto, V., Gorini, A., Moresco, R. M., Henin, M., Panzacchi, A., Matarrese, M., Carpinelli, A., Bellodi, L., & Fazio, F. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.04.233 · Cited by 219
“Our results provide a ground for an integrated therapeutic approach: as we already showed (Moresco et al., 2007), correlates of the treatment efficacy can be monitored with a functional neuroimaging approach in OCD.”
BackgroundMethodInfluentialSelf-citationDopaminergic control of cognitive flexibility in humans and animals
Klanker, M., Feenstra, M., & Denys, D. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00201 · Cited by 209
Fineberg, N. A., Apergis-Schoute, A. M., Vaghi, M. M., Banca, P., Gillan, C. M., Voon, V., Chamberlain, S. R., Cinosi, E., Reid, J., Shahper, S., et al. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx088 · Cited by 183
Vestibular insights into cognition and psychiatry
Gurvich, C., Maller, J. J., Lithgow, B., Haghgooie, S., & Kulkarni, J. (2013) · Brain Research · doi:10.1016/j.brainres.2013.08.058 · Cited by 178
Nikolaus, S., Antke, C., & Müller, H. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.06.009 · Cited by 143
Role of dopamine in the pathophysiology and treatment of obsessive–compulsive disorder
Koo, M.-S., Kim, E.-J., Roh, D., & Kim, C.-H. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.148 · Cited by 125
The application of deep brain stimulation in the treatment of psychiatric disorders
Graat, I., Figee, M., & Denys, D. A. J. P. (2017) · International Review of Psychiatry · doi:10.1080/09540261.2017.1282439 · Cited by 114
“In addition, striatal dopamine was increased in patients with OCD following DBS targeted at the NAc (Moresco et al., 2007), which parallels increased dopamine release after successful treatment of OCD with SRIs (Figee et al., 2014).”
BackgroundDopamine D1 receptor binding in the striatum of patients with obsessive–compulsive disorder
Olver, J. S., O'Keefe, G., Jones, G. R., Burrows, G. D., Tochon-Danguy, H. J., Ackermann, U., Scott, A., & Norman, T. R. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.06.020 · Cited by 88
“Previous studies have suggested there is a downregulation of dopamine D2 receptors in OCD patients compared with controls (Denys et al., 2004; Moresco et al., 2006) however no studies have yet reported on changes in the D1 receptor system in OCD patients.”
BackgroundResultNarayanaswamy, J., Hazari, N., & Venkatasubramanian, G. (2019) · Indian Journal of Psychiatry · doi:10.4103/psychiatry.indianjpsychiatry_525_18 · Cited by 82
“MAGNETIC RESONANCE SPECTROSCOPY Proton magnetic resonance spectroscopy (1H-MRS) allows in vivo quantification of specific neurochemicals in Indian Journal of Psychiatry, Volume 61 (Supplement 1), January 2019 S11 Table 1: Magnetic resonance imaging studies in obsessive-compulsive disorder Author, year Imaging n Contro…”
BackgroundInfluentialHu, X., Du, M., Chen, L., Li, L., Zhou, M., Zhang, L., Liu, Q., Lu, L., Mreedha, K., Huang, X., et al. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.04.012 · Cited by 75
“Moreover, a PET study demonstrated that fluvoxamine treatment could significantly improve clinical symptoms and increase[(11)C] Rac binding potential in the dorsal putamen of OCD patients (Moresco et al., 2007).”
BackgroundLissemore, J. I., Sookman, D., Gravel, P., Berney, A., Barsoum, A., Diksic, M., Nordahl, T. E., Pinard, G., Sibon, I., Cottraux, J., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0128-4 · Cited by 60
Murray, G. K., Knolle, F., Ersche, K. D., Craig, K. J., Abbott, S., Shabbir, S. S., Fineberg, N. A., Suckling, J., Sahakian, B. J., Bullmore, E. T., et al. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05292-2 · Cited by 53
Ramírez-Armenta, K. I., Alatriste-León, H., Verma-Rodríguez, A. K., Llanos-Moreno, A., Ramírez‐Jarquín, J. O., & Tecuapetla, F. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01161-9 · Cited by 52
“Previous studies have shown that SSRIs, such as fluvoxamine, increase the availability of D2 receptors and D2/D3 binding affinity, which has been associated with treatment effectiveness [57, 58].”
BackgroundSesia, T., Bizup, B., & Grace, A. A. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s146114571200154x · Cited by 49
“These results were then compared with their relative impact on the state of activity of the mesolimbic dopaminergic system using extracellular recoding of spontaneously active dopamine neurons in the ventral tegmental area (VTA).”
BackgroundResultKarpinski, M., Mattina, G., & Steiner, M. (2016) · Neuroendocrinology · doi:10.1159/000453664 · Cited by 40
Egerton, A., Ahmad, R., Hirani, E., & Grasby, P. M. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1226-4 · Cited by 53
“As pharmacological manipulation of these serotonergic inputs may provide a useful avenue in treatment of schizophrenia, substance abuse, and obsessive compulsive and affective disorders (Kapur and Remington 1996; Moresco et al. 2007; Rothman and Baumann 2006), interaction between 5-HT and DA systems is an important Ps…”
BackgroundApproach and avoidance learning in obsessive-compulsive disorder
Endrass, T., Kloft, L., Kaufmann, C., & Kathmann, N. (2011) · Depression and Anxiety · doi:10.1002/da.20772 · Cited by 44
“[22,23] Enhanced ERN amplitudes following response errors were consistently reported in OCD.”
BackgroundInfluentialBarahona-Corrêa, B., Camacho, M., Castro-Rodrigues, P., Costa, R. M., & Oliveira-Maia, A. J. (2015) · Frontiers in Psychology · doi:10.3389/fpsyg.2015.01798 · Cited by 41
Nikolaus, S., Mamlins, E., Hautzel, H., & Müller, H.-W. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0037 · Cited by 35
Moresco, R. M., Lavazza, T., Belloli, S., Lecchi, M., Pèzzola, A., Todde, S., Matarrese, M., Carpinelli, A., Turolla, E. A., Zimarino, V., et al. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0651-7 · Cited by 39
Self-citationNeuro-imaging the serotonin 2A receptor as a valid biomarker for canine behavioural disorders
Vermeire, S. T., Audenaert, K., Meester, R. H. D., Vandermeulen, E., Waelbers, T., Spiegeleer, B. M. J. D., Eersels, J. L. H., Dobbeleir, A. A., & Peremans, K. Y. (2010) · Research in Veterinary Science · doi:10.1016/j.rvsc.2010.09.021 · Cited by 37
Lower Posterior Cingulate Cortex Glutathione Levels in Obsessive-Compulsive Disorder
Brennan, B. P., Jensen, J. E., Perriello, C., Pope, H. G., Jenike, M. A., Hudson, J. I., Rauch, S. L., & Kaufman, M. J. (2015) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2015.12.003 · Cited by 37
Positron emission tomography in psychiatric disorders
Newberg, A. B., Moss, A., Monti, D., & Alavi, A. A. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06162.x · Cited by 30
Reduced striatal dopamine D 2/3 receptor availability in Body Dysmorphic Disorder
Vulink, N. C. C., Planting, R. S., Figee, M., Booij, J., & Denys, D. A. J. P. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.11.018 · Cited by 27
Poli, A., Pozza, A., Orrù, G., Conversano, C., Ciacchini, R., Pugi, D., Angelo, N. L., Angeletti, L. L., Miccoli, M., & Gemignani, A. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1063116 · Cited by 25
Yan, S., Liu, H., Yu, Y., Han, N., & Du, W. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.754165 · Cited by 29
Striatal Magnetic Resonance Spectroscopy Abnormalities in Young Adult Sapap3 Knockout Mice
Mintzopoulos, D., Gillis, T. E., Robertson, H. R., Dalia, T. N., Feng, G., Rauch, S. L., & Kaufman, M. J. (2015) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2015.10.001 · Cited by 26
New Pharmacotherapeutic Approaches to Obsessive-Compulsive Disorder
Figee, M., & Denys, D. A. J. P. (2009) · CNS Spectrums · doi:10.1017/s1092852900027255 · Cited by 26
Vulink, N. C. C., Westenberg, H. G. M., Nieuwerburgh, F. V., Deforce, D. L. D., Fluitman, S. B. A. H. A., Meinardi, J. C. M., & Denys, D. A. J. P. (2012) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2011.653375 · Cited by 29
Madrakian, T., Soleimani, M., & Afkhami, A. (2015) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2014.12.074 · Cited by 21
Lai, C., & Wu, Y. (2011) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.03.011 · Cited by 20
“Serotonin can regulate the level of dopamine, and Moresco et al. previously reported that fluvoxamine, a serotonin reuptake inhibitor, can also increase dopamine D2 receptor binding (Moresco et al., 2007).”
Kashyap, R., Eng, G. K., Bhattacharjee, S., Gupta, B., Ho, R., Ho, C. S. H., Zhang, M. W., Mahendran, R., Sim, K., & Chen, S. A. (2021) · Scientific Reports · doi:10.1038/s41598-020-80346-6 · Cited by 22
Altered Grooming Syntax and Amphetamine-Induced Dopamine Release in EAAT3 Overexpressing Mice
Escobar, A. P., Martínez-Pinto, J., Silva-Olivares, F., Sotomayor‐Zárate, R., & Moya, P. R. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.661478 · Cited by 15
“Interestingly, altered expression of DA system proteins in the striatum have been reported in neuroimaging studies of OCD (Denys et al., 2004; Hesse et al., 2005; Moresco et al., 2007).”
BackgroundYin, L., Han, F., & Wang, Q. (2023) · Cognitive Neurodynamics · doi:10.1007/s11571-023-09999-z · Cited by 16
“After the intake of dopaminergic drugs, PFC hyperactivity is reduced (Moresco et al. 2007; Pessina et al. 2009).”
The use of antipsychotics in obsessive compulsive disorder
Conti, D., Girone, N., Boscacci, M., Casati, L., Cassina, N., Cerolini, L., Giacovelli, L., Viganò, C. A., Conde, M. M., Cremaschi, L., et al. (2024) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2893 · Cited by 15
“PET studies showed an increase in D2 striatal receptors, which is suggestive of a decrease in dopaminergic tone in patients who are receiving SSRI chronic treatment (Moresco et al., 2007).”
BackgroundManagement of obsessive-compulsive disorder with fluvoxamine extended release
Fontenelle, L. F. (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s3301 · Cited by 15
The serotonergic system in obsessive-compulsive disorder
Derksen, M., Feenstra, M. G. P., Willuhn, I., & Denys, D. A. J. P. (2020) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-444-64125-0.00044-x · Cited by 17
Yamamuro, K., Ota, T., Iida, J., Kishimoto, N., Nakanishi, Y., Matsuura, H., Uratani, M., Okazaki, K., & Kishimoto, T. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.07.031 · Cited by 11
“Moresco et al. (2007) reported that the in vivo binding of [11C]raclopride ([11C]Rac) in the basal ganglia of OCD patients is improved by SSRI treatment.”
BackgroundLi, B., Lin, Y., Ren, C., Cheng, J., Zhang, Y., & Han, S. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.10.076 · Cited by 10
Role of Serotonin in Obsessive–Compulsive Disorder
van Dijk, A., Klompmakers, A. A., & Denys, D. A. J. P. (2008) · Future Neurology · doi:10.2217/14796708.3.5.589 · Cited by 10
“7%, following a 12-week treatment with fluvoxamine 150–300 mg [20].”
BackgroundPlasma fluvoxamine levels and OCD symptoms/response in adult patients
Marazziti, D., Baroni, S., Giannaccini, G., Piccinni, A., Picchetti, M., Massimetti, G., Schiavi, E., Palego, L., & Catena-Dell’Osso, M. (2012) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2240 · Cited by 9
“In addition, apart from binding to sigma 1 receptors, it has a low affinity for other receptors (Leonard, 1992; Hyttel, 1993; Moresco et al., 2007; Ago et al., 2011), in particular, histaminergic, adrenergic, or muscarinic receptors, which are responsible for the various sedative, cardiovascular, and anticholinergic s…”
BackgroundThe Serotonergic System in Obsessive-Compulsive Disorder
van Dijk, A., Klompmakers, A. A., & Denys, D. A. J. P. (2010) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(10)70100-4 · Cited by 9
Role of PET in the Investigation of Neuropsychiatric Disorders
Newberg, A. B., & Alavi, A. A. (2010) · PET Clinics · doi:10.1016/j.cpet.2010.03.003 · Cited by 8
Manning, E. E., Wang, A. Y., Saikali, L. M., Winner, A. S., & Ahmari, S. E. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/694935 · Cited by 8
Non-selective Effects of Selective Serotonin Reuptake Inhibitors
Zurowski, B., Kordon, A., Wahl, K., & Hohagen, F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.02.028 · Cited by 7
The Developmental Neurobiology of Repetitive Behavior
Kim, S., Lewis, M. H., & Veenstra-VanderWeele, J. M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397267-5.00039-x · Cited by 7
Neuroimaging of Obsessive-Compulsive Disorder: Insights into Serotonergic Mechanisms
Lissemore, J. I., Booij, L., Leyton, M., Gravel, P., Sookman, D., NORDAHL, T. E., & Benkelfat, C. (2020) · Springer eBooks · doi:10.1007/978-3-030-57231-0_13 · Cited by 4
Caravaggio, F., Porco, N., Iwata, Y., Nakajima, S., Gerretsen, P., Remington, G. J., & Graff‐Guerrero, A. (2020) · Journal of Obsessive-Compulsive and Related Disorders · doi:10.1016/j.jocrd.2020.100618 · Cited by 4
Positron emission tomography in neurological and psychiatric disorders
Newberg, A. B., Monti, D., Moss, A., & Alavi, A. A. (2012) · International Journal of Imaging Systems and Technology · doi:10.1002/ima.22004 · Cited by 4
Brain SPECT in the Behaviourally Disordered Dog
Dockx, R., Baeken, C., Vermeire, S. T., Waelbers, T., Xu, Y., Dobbeleir, A. A., Audenaert, K., & Peremans, K. Y. (2020) · Springer eBooks · doi:10.1007/978-3-030-57231-0_25 · Cited by 4
Molecular imaging of obsessive–compulsive disorder
Figee, M., Booij, J., & Denys, D. A. J. P. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511782091.019 · Cited by 3
Lissemore, J. I., Leyton, M., Gravel, P., Sookman, D., NORDAHL, T. E., & Benkelfat, C. (2014) · Springer eBooks · doi:10.1007/978-3-642-40384-2_17 · Cited by 4
Papikinos, T., Krokidis, M. G., Vrahatis, A. G., Vlamos, P., & Exarchos, T. P. (2024) · AIMS neuroscience · doi:10.3934/neuroscience.2024013 · Cited by 2
“Furthermore, Fluvoxamine, which is, as mentioned above, among the most common drugs used to treat OCD, has also been shown to target the D2 receptors in addition to its primary activity against SERT [10].”
BackgroundNeurobiologie der Zwangsstörung: Teil 2: Konzepte und Befunde aus der Neurobildgebung
Hohagen, F., Kordon, A., & Zurowski, B. (2009) · Nervenheilkunde · doi:10.1055/s-0038-1627159 · Cited by 1
Neurobiologie der Zwangsstörung: Teil 1: Konzepte zur Pathophysiologie und Genetik
Hohagen, F., Kordon, A., & Zurowski, B. (2009) · Nervenheilkunde · doi:10.1055/s-0038-1628687 · Cited by 3
Chapter 5.4 Principles and findings from human imaging of anxiety disorders
Malizia, A. L., & Nutt, D. J. (2008) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(07)00020-3 · Cited by 1
Nuclear medicine in psychiatry.
Lass, P., & Sławek, J. W. (2007) · PubMed
Brain SPECT in the Impulsive-Aggressive Dog
Peremans, K. Y., Vermeire, S. T., Waelbers, T., Vandermeulen, E., Dobbeleir, A. A., Spiegeleer, B. M. J. D., & Audenaert, K. (2014) · Springer eBooks · doi:10.1007/978-3-642-40384-2_26
Fluvoxamine-induced galactorrhea: A case series
Kotadia, H., Rawat, K., & Reddy, S. (2021) · Archives of Mental Health · doi:10.4103/2589-9171.311084
Axelsson, S. F. A. (2020) · Apollo (University of Cambridge) · doi:10.17863/cam.66759
Current Awareness in Contrast Media and Molecular Imaging
(2007) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.154
Current awareness in human psychopharmacology
(2007) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.795
Fluvoxamine-induced galactorrhea
Kotadia, H., Rawat, K., & Reddy, S. (2021) · Archives of Mental Health · doi:10.4103/amh.amh_54_20
Cremaschi, F., & Serrano, L. E. (2011) · NeuroTarget · doi:10.47924/neurotarget2011280 · Cited by 1
Pagliaccio, D. (2024) · Springer eBooks · doi:10.1007/978-3-031-32035-4_104-1
Les troubles psychiatriques résistants
Polosan, M. (2015) · Presses universitaires de Grenoble eBooks · doi:10.3917/pug.bouv.2015.01.0097
Pagliaccio, D. (2025) · Springer eBooks · doi:10.1007/978-3-031-73368-0_104
Prediction of Scrupulosity from Impulsivity, Religiosity, and Other Personal Characteristics
Chahine, J. K. (2025) · Deep Blue (University of Michigan) · doi:10.7302/28300
Metadata
- Authors
- Moresco, R. M., Pietra, L., Henin, M., Panzacchi, A., Locatelli, M., Bonaldi, L., Carpinelli, A., Gobbo, C., Bellodi, L., Perani, D., & Fazio, F.
- Affiliations
- Institute of Molecular Bioimaging and Physiology (IT)
- IRCCS Ospedale San Raffaele (IT)
- Vita-Salute San Raffaele University (IT)
- Corresponding author
- Moresco, Rosa Maria
- Venue
- Neuropsychopharmacology
- Published
- 2006-10-04
- Volume
- 32
- Issue
- 1
- Pages
- 197-205
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2048998525
- Cited by
- 70
- References
- 51
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 5 · 2020: 4 · 2019: 3 · 2018: 2 · 2017: 3 · 2016: 2 · 2015: 6 · 2014: 4 · 2013: 4 · 2012: 3
- FWCI
- 5.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- obsessive-compulsive disorder, fluvoxamine, dopamine D2 receptor, serotonin reuptake inhibitors, [11C]raclopride, basal ganglia, drug-naive patients
- MeSH terms
- Adult, Basal Ganglia, Brain Mapping, Carbon Isotopes, Female, Humans, Male, Middle Aged, Obsessive-Compulsive Disorder, Protein Binding, Tissue Distribution, Fluvoxamine, Selective Serotonin Reuptake Inhibitors, Receptors, Dopamine D2, Dopamine Antagonists, Raclopride, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.